[Formosa Pharmaceuticals] May 2026 Revenue Reaches NT$ 2.35 Million (Down 50.7% YoY)
NQ Score
31/100
N1 Content Completeness
3
AI Summary (NQ-processed)
Biotech company Formosa Pharmaceuticals (6838) announced its May 2026 revenue of NT$ 2.35 million, representing a 50.7% year-on-year decrease.
AI Analysis
Frequently Asked Questions
- Q: What is Formosa Pharmaceuticals' revenue for May 2026?
- A: The monthly revenue was NT$ 2,348 thousand (approx. NT$ 0.02 billion), down 50.7% year-on-year.
- Q: What sector does Formosa Pharmaceuticals operate in?
- A: It operates in the biotechnology and medical care sector in Taiwan.
- Q: What is the stock code of Formosa Pharmaceuticals?
- A: Its stock ticker code is 6838 in Taiwan.